Navigation Links
Emdeon Inc. Prices Initial Public Offering of Class A Common Stock at $15.50 Per Share
Date:8/11/2009

ch state or jurisdiction. The offering of these securities will be made only by means of a prospectus, copies of which may be obtained from Morgan Stanley & Co. Incorporated, Attention: Prospectus Department, 180 Varick Street, New York, New York 10014 (email address: prospectus@morganstanley.com); or Goldman, Sachs & Co., Attention: Prospectus Department, 85 Broad Street, New York, New York 10004 (email address: prospectus-ny@ny.email.gs.com) or by calling (212) 902-1171 or calling toll-free (866) 471-2526; or UBS Investment Bank, Attention: Prospectus Department, 299 Park Avenue, New York, New York 10171 or by calling toll-free (888) 827-7275; or Barclays Capital Inc., c/o Broadridge, Integrated Distribution Services, 1155 Long Island Avenue, Edgewood, New York, 11717 (email address: barclaysprospectus@broadridge.com), or by calling toll-free (888) 603-5847.

About Emdeon

Emdeon Inc. is a leading provider of revenue and payment cycle management solutions, connecting payers, providers and patients in the U.S. healthcare system. The Company's product and service offerings integrate and automate key business and administrative functions of its payer and provider customers throughout the patient encounter, including precare patient eligibility and benefits verification, claims management and adjudication, payment distribution, payment posting and denial management and patient billing and payment collection. Through the use of the Company's comprehensive suite of products and services, which are designed to easily integrate
'/>"/>

SOURCE Emdeon
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Emdeon Closes The Sentinel Group Acquisition, Implements First Customer in Less than 30 Days
2. Emdeon Inc. Commences U.S. Initial Public Offering of Class A Common Stock
3. Emdeon To Collaborate With Rx Response in Critical Pharmacy Disaster Reporting
4. Emdeon Acquires eRx Network, LLC
5. Emdeon Assistant Earns HFMA Peer Reviewed Certification for Second Year in a Row
6. Emdeon Announces Agreement to Acquire The Sentinel Group, a Leader in Healthcare Fraud and Abuse Management Services
7. Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare
8. Emdeon Selected by the Maryland Hospital Association to Power the Maryland Transaction Data Interchange
9. Nashvilles Emdeon Business Services to Co-Sponsor Democratic National Convention Health Policy Event
10. Emdeon Assistant Earns HFMAs Peer Review Designation
11. Emdeon Business Services Processes One Billionth Pharmacy Claim for Department of Defense and the U.S. Military Health System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...hysician-scientists from Weill Cornell Medical Col...y prove to be a powerful target for the treatment ...ffects lymphocytes, or white blood cells. By explo...o powerfully suppress tumor formation in lab testi...e led to the design of a clinical trial that will ...
(Date:11/22/2009)...& Machine post You Tube video demonstrating th... Landover, MD (PRWEB) Novemb...in learning what a really rugged waterproof keyboa...ool Keyboard vs Washable Competitors Keyboard HD&r...ow the premium, Really Cool Keyboard from Man &am...
(Date:11/21/2009)... Milvia Lopez, by her attorney MICH...led suit, in Supreme Court, New York County, beari... while Ms. Lopez underwent a routine transesophage...AL , doctors used an HIV infected scope exposing h...ral hours after being discharged from the procedur...
(Date:11/21/2009)...vative medical apparel company launches men,s lab ... San Clemente, Calif. (PRWEB) November 21,...cal apparel, today announced the launch of its men... a leading international trade fair for the medica...naugurates its men,s collection with three varying...
(Date:11/20/2009)...ist Closer to Understanding Brain Wiring and Disea...re/ -- Dr. Jeremy Schmahmann, Professor of Neurolo...e Massachusetts General Hospital in Boston, on Thu...earch on the new field of study called "Connectivi..., Dr. Schmahmann is an award-winning leader in the...
Breaking Medicine News(10 mins):Health News:New cancer target for non-Hodgkin's lymphoma 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
...ory for patient-centered medical home model, WASH... Collaborative (PCPCC) released the following stat...e bill, which includes a provision,for a $100 mill... medical home demonstration projects in Medicare w...
... 10 Omnicell, Inc.,(Nasdaq: OMCL ), a leading pr...ilities, will hold a conference call Monday, July ...nancial results., What: Omnicell second quart... Rob Seim, chief financial officer Where: ...
...fect developing brain,s ability to make neural con...News) -- Common underlying mechanisms that affect ...gly disparate gene mutations found in autistic peo...ople that appear to be tied to inherited mutations...
...mproves Kidney Care in America--Increased,Kidney C...fit, WASHINGTON, July 10 In response to the,pass...dney Care Partners,(KCP) -- an alliance of patient...nd kidney failure -- applauded the United,States S...
...wing is a,statement by Mark J. Feldman, DMD, Presi...ncement that 70 percent of the U.S. population now...me this very encouraging news from the Centers for...and,scientific study that community water fluorida...
...prove Genetic Healthcare and Educate Patients, SA... and,Iverson Genetic Diagnostics, Inc. today annou...personalized reports for individuals receiving,Ive... for Iverson customers, allowing physicians who wo...
Other Medicine News:Health News:Omnicell to Release Second Quarter 2008 Earnings Results on July 21 2Health News:Common Mechanisms May Contribute to Autism's Mutations 2Health News:Kidney Community Applauds Senate for Passage of End Stage Renal Disease (ESRD) Improvements 2Health News:DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results 2Health News:DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results 3
(Date:11/20/2009)..., , FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire...(NYSE: BDX ) today announced the completion of i...chigan-based company that develops and manufacture...orms. ,, In May 2009, BD and HandyLab announced...ercialize molecular assays on the HandyLab Jaguar(...
(Date:11/19/2009)..., , BIRMINGHAM, Ala., Nov. 19 /PRNewswire-F...q: BCRX ) today announced the pricing of a public...at $9.75 per share, resulting in gross proceeds of...red by BioCryst pursuant to an effective shelf reg...rities and Exchange Commission. BioCryst has also...
(Date:11/19/2009)..., , MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswir...aq: ALXA ) announced today that its corporate pre...ual Piper Jaffray Health Care Conference on Wednes...The presentation will be webcast from The New York... Thomas B. King, Alexza President and CEO. ,,...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Binghamton Research Group Develops New Cancer Treatment 5010 1Binghamton Research Group Develops New Cancer Treatment 5010 2Binghamton Research Group Develops New Cancer Treatment 5010 3Binghamton Research Group Develops New Cancer Treatment 5010 4HBV genotype B B3 and C C1 are the major genotypes in Indonesia 3F 57345 1Reactive oxygens role in metastasis 9946 1Reactive oxygens role in metastasis 9946 2
...ta Selected and Presented as,Platform Presentation...Technology,Demonstrates Optimal Functional Activit...-- Discovery,Laboratories, Inc. (Nasdaq:DSCO) anno...hase 2 clinical trial of Surfaxin(r),(lucinactant ...reatment of Bronchopulmonary Dysplasia (BPD) were ...
...May 8, 2007 - King,Pharmaceuticals, Inc. (NYSE:KG)... clinical trial for its ALTACE(R) (ramipril),diure...merican,Society of Hypertension,s Twenty-Second An...ay 19, 2007 at the Hyatt Regency Hotel,Chicago, I... for,review from 10 AM to 6 PM CDT. The Company pr...
Other Medicine Technology:Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 2Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 3Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 4Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 5Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 6Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 7King Pharmaceuticals Announces Plan to Present Results from Phase,III Clinical Trial Evaluating ALTACE as Monotherapy and in,Combination with Hydrochlorothiazide at the American Society of,Hypertension Annual Meeting 2
...n advanced scientific formulation that provides po...ct Plus is based on the AREDS clinical trial, and ...g the role of lutein in eye health. Featuring low ...nt blend of antioxidant nutrients and delivers 15 ...
...is a scientifically advanced nutritional formulati...nd full body health. MacularProtect Complete is ba... research. It features a comprehensive multinutrie...ntioxidants, such as 10 mg of FloraGLO® lutein...
Oculair
Ocuvite® Eye Vitamins and Mineral Supplement
Medicine Products: